首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   14114篇
  免费   951篇
  国内免费   427篇
耳鼻咽喉   187篇
儿科学   443篇
妇产科学   198篇
基础医学   1655篇
口腔科学   302篇
临床医学   1406篇
内科学   3002篇
皮肤病学   275篇
神经病学   916篇
特种医学   458篇
外国民族医学   2篇
外科学   1456篇
综合类   1142篇
现状与发展   1篇
一般理论   2篇
预防医学   1076篇
眼科学   486篇
药学   1089篇
  7篇
中国医学   387篇
肿瘤学   1002篇
  2024年   92篇
  2023年   180篇
  2022年   279篇
  2021年   472篇
  2020年   324篇
  2019年   381篇
  2018年   545篇
  2017年   393篇
  2016年   378篇
  2015年   504篇
  2014年   590篇
  2013年   684篇
  2012年   1004篇
  2011年   1071篇
  2010年   639篇
  2009年   438篇
  2008年   739篇
  2007年   766篇
  2006年   656篇
  2005年   710篇
  2004年   620篇
  2003年   601篇
  2002年   569篇
  2001年   462篇
  2000年   494篇
  1999年   391篇
  1998年   119篇
  1997年   98篇
  1996年   102篇
  1995年   90篇
  1994年   54篇
  1993年   51篇
  1992年   143篇
  1991年   118篇
  1990年   103篇
  1989年   108篇
  1988年   88篇
  1987年   75篇
  1986年   66篇
  1985年   53篇
  1984年   38篇
  1983年   23篇
  1982年   13篇
  1981年   9篇
  1980年   11篇
  1979年   14篇
  1977年   12篇
  1973年   9篇
  1970年   9篇
  1965年   8篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
目的 探讨抗中性粒细胞胞质髓过氧化物酶抗体相关性血管炎(MPO-AAV)患者中性粒细胞外捕网(NET)与滤泡辅助T细胞(Tfh)间关系及意义.方法 选择初诊未治疗的MPO-AAV患者和健康对照者各35例,流式细胞术(FCM)检测所有受试者外周血Tfh占CD4+T细胞分数(Tfh%)、表达 ICOS 的 Tfh 占 CD4+T 细胞分数(ICOS+Tfh%)及Tfh表达ICOS的平均强度(MFI);酶联免疫吸附试验(ELISA)法检测外周血MPO-ANCA、NET及IL-23水平,收集每例受试者的临床资料,评估每例患者病情活动度(BVAS-V3).结果 与健康对照组比较,MPO-AAV组外周血 Tfh%、ICOS+Tfh%、Tfh 的 MFI、NET 及 IL-23水平均高于对照组[分别为(25.7±3.9)%vs(20.7±5.3)%,P<0.001;(1.9±1.0)%vs(0.8±0.4)%,P<0.001;(59.5±10.3)vs(48.7±6.4)(MFI),P<0.001;(0.6±0.2)vs(0.2±0.1)(吸光度),P<0.001;(0.753 5±0.201 9)vs(0.237 5±0.087 0)(pg/L),P<0.001].双变量相关性分析提示MPO-ANCA水平分别与Tfh%及Tfh的MFI呈正相关(分别为r= 0.737,P<0.001;r = 0.628,P<0.001),但在多变量线性回归分析显示MPO-ANCA仅与Tfh%相关(P<0.001).IL-23分别与Tfh%、Tfh的MFI及NET水平呈正相关(分别为:r = 0.475,P = 0.004;r=0.359,P = 0.034;r =0.806,P<0.001).虽然双变量相关性分析提示Tfh%分别与外周血中NET及IL-23水平呈正相关(分别为:r= 0.714,P<0.001;r=0.480,P =0.004),但多变量线性回归分析显示Tfh%仅与NET水平呈正相关(P<0.001),即NET是影响Tfh%的独立因素.同时,结果显示NET与肾损害间存在相关性(r = 0.390,P= 0.021).结论 NET可能通过激活髓样树突状细胞提升Tfh%,以辅助B细胞产生特异性自身抗体 MPO-ANCA 参与 MPO-AAV 发病.  相似文献   
13.
目的:调查浙江温州地区三甲医院重症监护室医护人员对潮湿相关性皮肤损伤(MASD)的知信行现状,为提高监护室医护人员对MASD知信行水平提出切实可行的建议。方法:采用方便抽样法抽取三家三甲医院160名医护人员作为研究对象,通过一般资料调查表及MASD知信行调查问卷对其进行调查。结果:本研究共发放160份问卷,回收有效问卷共151份,有效回收率为94.38%。医护人员关于MASD知识、态度及行为的得分分别为(43.03±8.38)分、 (23.64±3.24)分和(13.98±3.16)分;不同工龄、职称、受教育程度医护人员知信行得分差异有统计学意义(P <0.05)。结论: 重症监护室医护人员对MASD的态度较积极,知识水平偏低,行为尚欠缺。其中医师对于皮肤问题的重视程度较低,医护人员的合作意识欠缺,对此需开展针对性培训,提高医护人员相关理论知识及合作行为能力,规范MASD的预防及处理方法。  相似文献   
14.
15.
16.
Prior research on callous-unemotional (CU) traits supports a deficit in recognizing fear in faces and body postures. Difficulties recognising others’ emotions may impair the typical behavioural inhibition for violent behaviour. However, recent research has begun to examine other distress cues such as pain. The present study examined emotion recognition skills, including pain, of school-excluded boys aged 11–16 years (N = 50). Using dynamic faces and body poses, we examined the relation between emotion recognition and CU traits using the youth psychopathic traits inventory (YPI) and the inventory of CU traits. Violent delinquency was covaried in regression analyses. Although fearful facial and fearful bodily expressions were unrelated to CU traits, recognition of dynamic pain facial expressions was negatively related to CU traits using the YPI. The failure to replicate a fear and sad deficit are discussed in relation to previous research. Also, findings are discussed in support of a general empathy deficit for distress cues which may underlie the problem behaviour of young males with CU traits.  相似文献   
17.
The aim of this study was to evaluate whether contrast enhanced fluid attenuated inversion recovery (CE-FLAIR) imaging can be used to predict the severity of meningitis based on leptomeningeal enhancement (LE) score and cerebrospinal fluid signal intensity (CSF-SI) on CE-FLAIR. We retrospectively analyzed data collected from 43 consecutive patients admitted to our hospital due to meningitis. Clinical factors including initial Glasgow Coma Scale (GCS) score, CSF glucose ratio, log CSF protein, log CSF WBC, and prognosis were evaluated. The LE score was semi-quantitatively scored, and we evaluated CSF-SI ratio at the interpeduncular or quadrigerminal cisterns on CE-FLAIR. We evaluated the differences in clinical variables, LE scores and CSF-SI ratios between the recovery and the complication group. We assessed the correlation between clinical variables, LE scores and CSF-SI ratios. The values of log CSF protein, CSF-SI ratio, and LE score were significantly higher in the complication group (p value <0.05). GCS score and CSF glucose ratio were significantly lower in the complication group (p value <0.01). The LE scores had significant negative correlation with GCS scores and CSF glucose ratios (p value <0.001). The LE score was significantly positively correlated with the value of log CSF protein and CSF-SI ratio (p value <0.01). The CSF-SI ratio was negatively correlated with GCS score and CSF glucose ratio (p value <0.01). The CSF-SI ratio was positively correlated with the value of log CSF protein (p value <0.05). Our results suggest that LE score and CSF-SI ratio are well correlated with clinical prognostic factors. We may predict the clinical severity of meningitis by using LE scores and CSF-SI ration on CE-FLAIR imaging.  相似文献   
18.
GFR decline in patients with CKD has been widely approximated using linear models, but this linearity assumption is not well validated. We conducted a matched case-control study in children from the Chronic Kidney Disease in Children (CKiD) cohort ages 1–16 years with mild to moderate CKD to assess whether GFR decline follows a nonlinear trajectory as CKD approaches ESRD. Children (n=125) who initiated RRT (cases) during follow-up were individually matched by CKD stage at baseline and glomerular/nonglomerular diagnosis with children (n=125) who remained RRT-free when the corresponding case initiated RRT (controls). GFR trajectories were compared using log-linear and piecewise log-linear mixed effects models adjusted for baseline characteristics. From study entry to 18 months before RRT, GFR declined 7% faster among cases compared with controls. However, GFR declined 26% faster among cases compared with controls (P<0.001) during the 18 months before RRT. Nonlinearity in the rate of kidney function loss, which was shown in this cohort, may preclude accurate clinical prediction of the timing of RRT and adequate patient preparation. This study should prompt the characterization of predictive factors that may contribute to an acceleration of kidney function decline.GFR is a key measurement of kidney function, and the degree of GFR decline over time is a reflection of the severity of CKD progression. GFR decline has been approximated as linear or log-linear in most analyses of progression, an assumption that has been consistent with available data.14 However, many studies rely on relatively short follow-up periods and few repeated measures. Given the convenience of assuming a linear GFR trajectory, which results from the ease of modeling and interpreting linear slopes, few studies have sought to validate the linearity assumption and explore the possibility of nonlinear GFR decline. However, nonlinearity in GFR decline has been observed in some epidemiologic studies,57 and the implications on the risk for adverse outcomes have generated interest.8 A CKD cohort study in France found that about one half of its patients experienced nonlinear GFR decline during the last year before dialysis.5 A study by Li et al.9 used a flexible approach to model nonlinearity in GFR trajectories. Li et al.9 found evidence of nonlinear GFR trajectory behavior in adult patients with CKD, and furthermore, the probability of having nonlinear features in an individual trajectory was associated with known risk factors for CKD progression. O’Hare et al.10 found several distinct nonlinear patterns of GFR decline in the 2 years before dialysis initiation in Veterans Affairs patients.Clinical strategies and subsequent patient response to care could potentially benefit from new insights into the variable paths of progression in patients with CKD.10,11 The question of whether characterizing the nonlinearity in the GFR trajectory can assist the identification of risk groups for outcomes, such as ESRD, remains unexplored. The implications on future outcomes of an increased rate of GFR decline could inform clinical decisions about screening frequencies, treatment, or preparation for RRT.The Chronic Kidney Disease in Children (CKiD) study is an ongoing cohort study of children with CKD who, at baseline, had an eGFR between 30 and 90 ml/min per 1.73 m3 and were ages 1–16 years. An end point of the study is RRT defined as transplant or dialysis. To determine whether trajectories of GFR accelerate before RRT, we nested a case-control study, in which cases were children observed to have received RRT and controls were children with CKD who remained RRT-free at the time when the corresponding case initiated RRT.There were 147 children who experienced RRT during follow-up. Each case was matched individually to an eligible control at the time of the case occurrence. The matching factors included baseline CKD stage, glomerular/nonglomerular diagnosis, and, through design, the amount of follow-up time from study entry. Matching was done without replacement, and 22 cases were excluded from the analyses, because no appropriate control was available. We used a random sequence to determine the order of matching. The analysis was, thus, based on 125 matched case-control pairs. Demographic and clinical characteristics of cases and controls at baseline are shown in
CharacteristicsCases (n=125)Controls (n=125)
Age, yr12.64 (9.23–14.53)12.33 (8.71–14.74)
Sex (girls), N (%)38 (30.4)57 (45.6)
Race (nonwhite), N (%)51 (40.8)36 (28.8)
Urine protein/creatinine ratio1.74 (0.48–4.04)0.60 (0.26–1.76)
Proteinuria, N (%)
 0.2≤protein/creatinine ratio<256 (46.7)71 (59.7)
 Protein/creatinine ratio≥251 (42.5)23 (19.3)
Baseline GFRa32.21 (26.43–39.64)35.77 (27.86–43.78)
Glomerular diagnosis, N (%)a47 (37.6)47 (37.6)
Open in a separate windowMedian (interquartile range) unless otherwise indicated.aBaseline GFR and glomerular/nonglomerular diagnosis were matching factors.We compared the GFR trajectories using log-linear and piecewise log-linear mixed effects models, with the piecewise model specified to allow a change of the GFR slope at 18 months before RRT. Models were adjusted for baseline characteristics, including age, race, sex, and proteinuria status. and33 show the adjusted results from the mixed effects model analyses. The Akaike Information Criterion indicated that the piecewise log-linear model (including a spline or changing slope at 18 months before RRT) was a better fit to the data than the log-linear model that assumed a single slope across the entire period of observation. The GFR of cases declined at an adjusted rate of 6.8% per year (P <0.001) during the time before the spline in the earlier period of observation and 32.4% per year (P <0.001) after the spline within 18 months of RRT. The GFR of controls did not change significantly (P=1.00) before the spline and declined at an adjusted rate of 9.0% (P <0.001) after the spline. Although the rates of GFR decline comparing cases with controls differed by only 7% before the spline, the GFR of cases declined 26% faster (P <0.001) compared with controls within 18 months of RRT, suggesting an acceleration in the GFR decline during this period in the case group. This acceleration, which was quantified by the piecewise log-linear mixed effects model, could be clearly seen from the data and nonparametric smooth fits (Figure 1). The variability around the piecewise log-linear fit was assessed by the root mean square error (RMSE) and found to be similar between cases and controls (RMSE for controls=0.303; RMSE for cases=0.303), indicating an equally good fit. When a single slope was fit to the data, the GFR decline rate for cases was overestimated before the spline and considerably underestimated within 18 months of RRT. To assess whether the acceleration in decline was a function of the log scale, models were rerun with GFR in the natural scale. The results showed similar nonlinear patterns but a poorer model fit to the data.

Table 2.

The adjusted expected percent GFR change rates in the log-linear mixed effects model
Case GroupAdjusted % GFR Change per YearSEM (%)P Value
Controls−3.21.20.01
Cases−18.20.9<0.001
Cases-controls−15.51.3<0.001
AIC260.78
Open in a separate windowParameter estimates from the models are provided in Supplemental Appendix II. All results were adjusted for baseline characteristics, including age, race, sex, and proteinuria status. AIC, Akaike Information Criterion.

Table 3.

The adjusted expected percent GFR change rates in the piecewise log-linear mixed effects model
Case GroupBefore 18 mo before RRT of CasesAfter 18 mo before RRT of CasesDifference between Early and Late Slopesa
Adjusted % GFR Change per YearSEM (%)P ValueAdjusted % GFR Change per YearSEM (%)P ValueAdjusted % GFR Change per YearSEM (%)P Value
Controls0.31.50.87−9.02.5<0.0019.23.30.01
Cases−6.81.3<0.001−32.41.3<0.00127.42.0<0.001
Cases-controls−7.01.9<0.001−25.72.5<0.001
AIC149.14
Open in a separate windowParameter estimates from the models are provided in Supplemental Appendix II. All results were adjusted for baseline characteristics, including age, race, sex, and proteinuria status.aDifference resulting from the piecewise linear mixed effects model estimated in the log scale and then exponentiated.Open in a separate windowFigure 1.Nonlinear GFR decline before RRT can be approximated with a piece-wise log-linear model. A and B show the smooth fit of log GFR over time for cases of RRT and matched controls anchoring at the RRT onset time of cases. C and D show the fit from the adjusted log-linear and adjusted piecewise log-linear mixed effects models for cases of RRT and matched controls anchoring at the RRT onset time of cases. Models were adjusted for baseline characteristics including age, race, sex, and proteinuria status.Our results show that, although linear or log-linear GFR decline is a convenient assumption for longitudinal studies of CKD progression, individuals experience periods of accelerated decline. Li et al.9 showed that patients in the African American Study of Kidney Disease and Hypertension experienced a variety of nonlinear progression patterns. O’Hare et al.10 classified CKD patients who progressed to dialysis into four GFR trajectory categories and found evidence that patients with mild to moderate CKD experienced more rapid renal function deterioration in the 2 years before reaching long-term dialysis. In the current study assessing progression in children with CKD, we found similar results, indicating that RRT events are preceded by a period of accelerated decline in GFR. It is likely that this period of precipitous loss in kidney function is a key factor in the determination of the timing of RRT. An acceleration of GFR decline may be a primary feature of a worsening clinical profile that prompts a clinician to initiate dialysis or transplant. The question arises as to what contributes to accelerated kidney function loss. A primary epidemiologic challenge is to find predictors that antecede the acceleration and are amenable to intervention to prevent or delay such accelerated loss and RRT. Clearly, these results and the questions that they raise speak to a need for additional investigations of CKD progression in various populations, with care taken to appropriately characterize changing levels of factors that are known predictors of CKD progression. The timing of potential insults to the kidney (e.g., loss of control of BP) may hold important information concerning the patterns of CKD progression and nonprogression. O’Hare et al.10 found that rates of recommended pre-ESRD care were lower for those patients experiencing the most rapid progression before dialysis initiation. Ambrogi et al.5 suggested that nonlinear patterns in GFR decline might create difficulty in estimating the timing of dialysis.These results may also highlight the coarseness of current methods for assessing the impact of risk factors on CKD progression, which mainly rely on the assumption of linear decline in kidney function. Analyses assuming linear decline average over nonlinear patterns that speak to the true nature of the exposure–outcome relationships. More sensitive analyses may be needed to characterize the heterogeneity in the patterns that describe CKD progression and assess the impact of often changing values of the exposure. Improvements in how we characterize patterns of progression could lead to new approaches to clinical care, because accelerations in kidney function loss may complicate the timing of RRT and pre-ESRD care.7,10There are several strengths of this study. We drew from a well characterized cohort of children with CKD with directly measured GFR at the first two annual study visits and all even visits thereafter. The CKiD study also has an internally derived estimating equation for GFR to capture kidney function in odd visit years of the study, thereby providing regular GFR assessments for characterizing nonlinear patterns of GFR decline. The CKiD study has longitudinal data for up to 6 years of follow-up, and the multicenter setting with 43 clinical sites provides a sample of children highly representative of the pediatric CKD population in care in the United States. By adopting the case-control design, we were able to compare the nonlinearity of the GFR trajectory before RRT with the expected trajectory in comparable children who had not yet experienced RRT.There are also notable limitations to the current analysis. There were only 125 case-control pairs, and our GFR assessments were annual, limiting the degree to which heterogeneity in progression to RRT could be assessed among the case group. As has been reported previously, there is likely variation in GFR patterns before RRT.10 However, what is clear from the current study is that, on average, children approaching RRT experience acceleration in their loss of kidney function. Another consideration is the assumption of a break in linearity at 18 months before RRT, which provided sufficient data before and after the spline for our analyses but is an oversimplification of what is likely a more prolonged period of acceleration in GFR decline. However, our choice of 18 months before RRT to examine changes in the rate of GFR decline is consistent with other studies that have noted similar rapid declines in kidney function within 2 years of dialysis.10,12 Finally, it should be noted that, although cases and controls were matched, the models in and33 did not cluster on the matched pairs. Our final model provided practically identical results to a model including an additional random effect for case-control pair, and it had modestly higher precision.  相似文献   
19.
Microwave coagulation therapy and drug injection to treat splenic injury     
Guoming Zhang  MD  Yuanyuan Sun  Nannan Mu  Lanfen LiuPing Liang  MD 《The Journal of surgical research》2014

Background

The present study compares the efficacy of 915- and 2450-MHz contrast-enhanced ultrasound (CEUS)–guided percutaneous microwave coagulation with that of CEUS-guided thrombin injection for the treatment of trauma-induced spleen hemorrhage.

Materials and methods

In a canine splenic artery hemorrhage model with two levels of arterial diameter (A, <1 mm and B, between 1 and 2 mm), hemostatic therapy was performed using 915- and 2450-MHz microwaves and drug injection. Therapy efficacy was measured by comparing bleeding rate, hemostatic time, bleeding index, bleeding volume, and pathology.

Results

The most efficient technique was CEUS-guided 915-MHz percutaneous microwave coagulation therapy in terms of action time and total blood loss. The success rate of the 915-MHz microwave group was higher than that of the 2450-MHz microwave and the drug injection groups (except A level, P < 0.05). Hemostatic time, bleeding index, and bleeding volume were significantly less in the 915-MHz microwave group than those in the 2450-MHz microwave and drug injection groups (P < 0.05). Obvious degeneration and necrosis of parenchyma and large intravascular thrombosis were observed in the cavity of larger vessels in the 915-MHz microwave group, but pathologic changes of light injury could be seen in the other groups.

Conclusions

The present study provides evidence that microwave coagulation therapy is more efficient than thrombin injection for the treatment of splenic hemorrhage. Furthermore, treatment with 915-MHz microwaves stops bleeding more rapidly and generates a wider cauterization zone than does treatment with 2450-MHz microwaves.  相似文献   
20.
The distribution of lymph nodes and their nutrient vessels in the groin region: An anatomic study for design of the lymph node flap     
Han Zhang M.D.  Ph.D.  Weiwei Chen M.D.  Ph.D.  Lan Mu M.D.  Ph.D.  Ru Chen M.D.  Ph.D.  Jie Luan M.D.  Ph.D.  Dali Mu M.D.  Ph.D.  Chunjun Liu M.D.  Ph.D.  Minqiang Xin M.D.  Ph.D. 《Microsurgery》2014,34(7):558-561
  相似文献   
[首页] « 上一页 [1] 2 [3] [4] [5] [6] [7] [8] [9] [10] [11] 下一页 » 末  页»
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号